VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
2.500
+0.110 (4.60%)
Dec 20, 2024, 4:00 PM EST - Market closed
VYNE Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for VYNE Therapeutics stock have an average target of 6.88, with a low estimate of 5.75 and a high estimate of 8.00. The average target predicts an increase of 175.20% from the current stock price of 2.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 18, 2024.
Analyst Ratings
The average analyst rating for VYNE stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +220.00% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +130.00% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +130.00% | Sep 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +130.00% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +130.00% | Jun 14, 2024 |
Financial Forecast
Revenue This Year
544.00K
from 424.00K
Increased by 28.30%
Revenue Next Year
255.00K
from 544.00K
Decreased by -53.12%
EPS This Year
-0.76
from -2.78
EPS Next Year
-1.15
from -0.76
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 630,000 | 525,000 | 630,000 | ||
| Avg | 543,997 | 255,000 | 306,000 | ||
| Low | 490,000 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 48.6% | -3.5% | 147.1% | ||
| Avg | 28.3% | -53.1% | 20.0% | ||
| Low | 15.6% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.10 | -1.10 | -0.99 |
| Avg | -0.76 | -1.15 | -1.18 |
| Low | -0.96 | -1.19 | -1.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.